Mayo Clinic. US: In an international study, Mayo Clinic researchers and
collaborators have identified genetic markers that may help in
identifying individuals who could benefit from the alcoholism treatment
drug acamprosate (Campral). The findings, published in the journal Translational Psychiatry,
show that patients carrying these genetic variants have longer periods
of abstinence during the first three months of acamprosate treatment.
Only good, independent and reliable information about health from experts.
Showing posts with label acamprosate. Show all posts
Showing posts with label acamprosate. Show all posts
Monday, January 5, 2015
Acamprosate
Acamprosate calcium is used in the treatment
of alcohol dependence. It works by reducing the desire or craving to
drink alcohol. It is only given to people who have successfully stopped
drinking. Acamprosate calcium helps to reduce the chances of you
drinking again. People who are taking Acamprosate calcium will usually
have a programme of counselling as part of their treatment. Treatment
with Acamprosate calcium usually lasts one year.
Subscribe to:
Posts (Atom)